Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name S095029
Trade Name
Synonyms S-095029|S 095029|Sym 025|Sym-025|Sym025
Drug Descriptions

S095029 is a monoclonal antibody that targets natural killer (NK) and T-lymphocyte cell checkpoint inhibitor killer cell lectin-like receptor subfamily C member 1 (NKG2A), which may result in an antitumor immune response mediated by NK cells and cytotoxic T-lymphocytes (NCI Drug Dictionary).

DrugClasses NKG2A Antibody 3
CAS Registry Number NA
NCIT ID C185890

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cemiplimab + S095029 Cemiplimab S095029 0 1
Futuximab + S095029 + Sym021 Futuximab S095029 Sym021 0 1
Modotuximab + S095029 + Sym021 Modotuximab S095029 Sym021 0 1
Pembrolizumab + S095029 Pembrolizumab S095029 0 1
S095029 S095029 0 1
S095029 + Sym021 S095029 Sym021 0 1


Additional content available in CKB BOOST